← Back to Search

Observational for Cancer

N/A
Recruiting
Led By John B. Kisiel, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (samples collected at enrollment)
Awards & highlights

Study Summary

This study explores the potential value of a new blood test approach for early detection of cancer.

Eligible Conditions
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (samples collected at enrollment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (samples collected at enrollment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cancer specific site prediction - blood samples/MDM
Cancer specific site prediction - blood samples/RNA
Cancer specific site prediction - urine samples/MDM
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo blood, urine, and/or residual tissue sample collection and have their medical records reviewed on study.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,208 Previous Clinical Trials
3,761,200 Total Patients Enrolled
John B. Kisiel, M.D.Principal InvestigatorMayo Clinic in Rochester
3 Previous Clinical Trials
10,800 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2600 spots leftby May 2028